To address these issues, we examined in vivo and in vitro whether chronic infusion of Ang-(1–7) may dose-dependently ameliorate LV remodeling and function in a rat model of DCM, and whether Ang-(1–7) and ACE inhibition combined may be superior to single therapy. The gene discussed is ACE; the disease is familial dilated cardiomyopathy.